珠海都市网
您当前的位置 :首页 > 文传商讯 > 正文
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Tria
2023年10月16日 22:03:59来源:作者:

Following Pfizer’s abrupt discontinuation of Care Access study participants,
the FDA inspection finds no violations

BOSTON--(BUSINESS WIRE)--Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial. The inspection resulted in no FDA Form 483 observations, meaning the FDA investigator found no GCP violations by Care Access in the VALOR trial. The FDA inspection lasted from October 2nd to October 10th, 2023, and was an in-depth review of Care Access’s contributions to the trial, including with respect to general GCP requirements, patient safety, and data integrity.

Earlier this year, Pfizer discontinued over 3,000 participants at Care Access sites on the study due to alleged GCP violations. Care Access disagreed with Pfizer’s decision and rejected the allegations. The lack of any findings by the FDA investigator is wholly consistent with Care Access’s assertions that there were no GCP violations.

“We couldn’t be prouder of our team,” said Care Access CEO Ahmad Namvargolian. “This confirms what we’ve known all along about Care Access’ outstanding systems and controls to ensure regulatory compliance and patient safety on all the studies it performs. We’re very glad to have had the opportunity finally to undergo this independent, searching review by an FDA expert, which confirmed what we’ve always said about our performance on the VALOR trial and beyond.”

The Pfizer VALOR study is ongoing and seeks to determine the safety and efficacy of a potential Vaccine for Lyme Disease. Care Access had deployed its unique decentralized model to bring this study to previously unreachable communities that are most impacted by Lyme Disease. With a fleet of mobile research vehicles and a team of traveling research professionals, Care Access specializes in having clinical research meet the needs of a community, not the other way around.

About Care Access

Care Access is a global research company helping to accelerate the arrival of new medicines. With a global network of over 150 research sites, Care Access supports research studies conducted by 14 of the top 20 biopharmaceutical companies. In addition to its proven track record of globally top-enrolling sites, Care Access partners with new-to-research communities and establishes high-quality research site infrastructure locally to expand access to clinical trials and increase representation.

To learn more visit www.careaccess.com.

责任编辑: admin

看新闻,关注新闻

其它网友:偏心   ■
评论:食堂一直是个大问题 最近越来越怀疑那些食堂的人究竟是炊事员还是饲养员 ...

天猫网友:zore/. 极乐
评论:> 有人争取,就会有人失去

腾讯网友:空心 Vicious▽
评论:我来到我们来过的小路,捡起我们可耻的幸福。

网易网友:楓獨洎薸蓅
评论:你玩儿的叫潜水,哥玩儿的叫潜伏

本网网友:若凌° Provence -
评论:不为人知的猥琐是闷骚,无伤大雅的猥琐是情调。

淘宝网友:柔眸1  Demon
评论:我还没年轻到什么都懂的地步。

猫扑网友:人身尽情挥霍
评论:你打扮成这样,是对这个世界有什么不满吗?

天涯网友:念而不忘  7mr°
评论:最郁闷的是:网上购票,钱从账户划去了,票没出来。

百度网友:Paranoid. 偏执
评论:人生四项基本原则:懂得选择,学会放弃,耐得住寂寞,经得起诱惑。

搜狐网友:笨笨Forever〃
评论:姐姐曾对我说:妹子你真好看!背面看,想犯罪;侧面看,想到退;正面看,想正当防卫。

相关阅读
分享到:
版权和免责申明

珠海都市网所有文字、图片、视频、音频等资料均来自互联网,不代表本站赞同其观点,本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实,如果您发现本网站上有侵犯您的合法权益的内容,请联系我们,本网站将立即予以删除!